← Open Payments lookup

JEFFREY LANDON: Open Payments

NPI 1043641236 · NATIONAL CITY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,031 in 151 payments from 13 companies in 2025. Trend: 2023 $921 · 2024 $1,602 · 2025 $3,031

Food & beverage: $3,031
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.28$635
Otsuka America Pharmaceutical, Inc.17$372
Teva Pharmaceuticals USA, Inc.18$329
ABBVIE INC.15$302
Alkermes, Inc.17$278
Vanda Pharmaceuticals Inc.11$239
E.R. Squibb & Sons, L.L.C.20$232
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$231
Lundbeck LLC5$119
Axsome Therapeutics, Inc.4$103

Products named: INGREZZA, REXULTI, ARISTADA, VRAYLAR, UZEDY, FANAPT, COBENFY, CAPLYTA.

Industry payments across CA — which companies pay providers there.